Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus [NA]
A clinical trial examines glucocorticoid withdrawal in early systemic lupus erythematosus. The trial status is currently unknown.
-
FDA approval · 2019-01-15FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved a generic hydroxychloroquine sulfate product under an Original Application from Rising Pharma Holdings, Inc. for use in tre…
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus [Phase 2]
Phase 2 safety and efficacy study of a biologic for systemic lupus erythematosus has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 trial of baricitinib in systemic lupus erythematosus completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus. [Phase 2]
Phase 2 clinical trial evaluating safety and tolerability of MEDI-545 (injection) in patients with systemic lupus erythematosus has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus [Phase 1]
Phase I study of belimumab in Chinese subjects with systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients [Phase 1]
Phase 1 trial updating safety and effectiveness of Gardasil in patients with systemic lupus erythematosus completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus [Phase 3]
Open-label extension study of Epratuzumab in systemic lupus erythematosus completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]
Clinical trial update for nonmyeloablative conditioning and transplantation in refractory systemic lupus erythematosus (SLE) has terminated;…
-
FDA approval · 2018-08-23FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept (mycophenolate mofetil) filed by Genentech, Inc. The approval updates the labeling and/…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy [Phase 2]
Phase 2 pediatric trial results for belimumab added to background standard therapy in systemic lupus erythematosus have been completed and r…
-
CLINICAL_TRIALS research · 2018-07-12Clinical Trial Update: Autophagy in Systemic Lupus Erythematosus
This document provides an update on a clinical trial investigating autophagy in patients with Systemic Lupus Erythematosus, with the current…
-
FDA approval · 2018-07-06FDA Approved: HYDROXYCHLOROQUINE — Original Application (Chartwell RX, LLC)
FDA approved an original application for a generic hydroxychloroquine product (ANDA210543) developed by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial comparing epratuzumab to placebo in moderate to severe systemic lupus erythematosus has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) [Phase 3]
Phase 3 trial comparing epratuzumab to placebo in adults with moderate to severe systemic lupus erythematosus has completed; results posted …
-
CLINICAL_TRIALS research · 2018-06-28Clinical Trial Update: Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
Clinical trial update describing interval monitoring for systemic lupus erythematosus to detect disease flares and optimize treatment, spons…
-
FDA approval · 2018-06-22FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BENLYSTA (belimumab) filed by GlaxoSmithKline LLC.
-
FDA approval · 2018-06-22FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for BENLYSTA (belimumab) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: A Study of LY2127399 in Participants With Systemic Lupus Erythematosus [Phase 3]
A Phase 3 trial evaluating LY2127399 (tabalumab) for systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-18Clinical Trial Update: Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE) [Phase 1]
This Phase 1 trial evaluated vitamin D therapy in patients with Systemic Lupus Erythematosus. The study sponsored by the Medical University …
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Intervention to Improve Quality of Life in African American Lupus Patients [NA]
Clinical trial update describing an intervention intended to improve quality of life for African American patients with systemic lupus eryth…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus [Phase 3]
The Phase 3 trial of tabalumab (LY2127399) for systemic lupus erythematosus, using two injection methods, was terminated. Results were poste…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Study of LY2127399 in Participants With Systemic Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial of LY2127399 in systemic lupus erythematosus has completed enrollment and posted results. The sponsor is Eli Lilly …
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus [Phase 2]
Phase 2a trial evaluating the efficacy and safety of ustekinumab in systemic lupus erythematosus has completed and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus [Phase 2]
Phase 2 dose-ranging trial of Adcetris (brentuximab vedotin) in adults with systemic lupus erythematosus was terminated; results were posted…